{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:54:22Z","timestamp":1787698462147,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI19\/01231"],"award-info":[{"award-number":["PI19\/01231"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omton.2025.201032","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T15:00:30Z","timestamp":1754751630000},"page":"201032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Aurora kinase A drives non-canonical YAP1\/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer"],"prefix":"10.1016","volume":"33","author":[{"given":"Anxo","family":"Rio-Vilari\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garcia-Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiora","family":"Cenigaonandia-Campillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Mateos-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina I.","family":"Schlaepfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Garcia-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura del","family":"Puerto-Nevado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ba\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Minguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor Manuel","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Garcia-Foncillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arancha","family":"Cebrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201032_bib1","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/annonc\/mdx501","article-title":"Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review","volume":"28","author":"Garc\u00eda-Foncillas","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omton.2025.201032_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.omton.2025.201032_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omton.2025.201032_bib4","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.18632\/oncotarget.14012","article-title":"Mechanisms of resistance to anti-EGFR therapy in colorectal cancer","volume":"8","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2025.201032_bib5","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/cells9061392","article-title":"The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma","volume":"9","author":"Das","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omton.2025.201032_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5416923","article-title":"Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.omton.2025.201032_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","article-title":"Drug resistance and Cancer stem cells","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omton.2025.201032_bib8","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1038\/s41467-021-26967-5","article-title":"ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation","volume":"12","author":"Gu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201032_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7150\/jca.77322","article-title":"Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2\/YAP1 axis of the hippo signaling pathway","volume":"14","author":"Wang","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.omton.2025.201032_bib10","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.7150\/jca.48891","article-title":"Cyr61 mediates oxaliplatin resistance in colorectal cancer cells by regulating Bcl-xL expression","volume":"12","author":"Song","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.omton.2025.201032_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/1078-0432.CCR-14-1374","article-title":"Significant association of oncogene YAP1 with poor prognosis and cetuximab resistance in colorectal cancer patients","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201032_bib12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.7150\/thno.18175","article-title":"The YAP1\/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer","volume":"7","author":"Wu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.omton.2025.201032_bib13","first-page":"1","article-title":"Inhibition of the AURKA\/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells","volume":"130","author":"Rio-Vilari\u00f1o","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2025.201032_bib14","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1074\/jbc.RA118.002715","article-title":"The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell","volume":"293","author":"Plouffe","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201032_bib15","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2025.201032_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14262","article-title":"Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors","volume":"8","author":"Sch\u00fctte","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201032_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/cancers11020235","article-title":"Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer","volume":"11","author":"Felipe-Abrio","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2025.201032_bib18","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.3748\/wjg.v19.i17.2603","article-title":"CD133: A cancer stem cells marker, is used in colorectal cancers","volume":"19","author":"Ren","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omton.2025.201032_bib19","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.devcel.2022.11.015","article-title":"\u0394Np63\/p73 Drive Metastatic Colonization by Controlling a Regenerative Epithelial Stem Cell Program in Quasi-mesenchymal Cancer Stem Cells","volume":"57","author":"Lambert","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omton.2025.201032_bib20","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1158\/1535-7163.MCT-18-0694","article-title":"Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer","volume":"17","author":"Sunakawa","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omton.2025.201032_bib21","doi-asserted-by":"crossref","first-page":"56699","DOI":"10.18632\/oncotarget.11057","article-title":"Regulation of cellular quiescence by YAP\/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse","volume":"7","author":"Corvaisier","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2025.201032_bib22","first-page":"2171","article-title":"Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells","volume":"40","author":"Liu","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2025.201032_bib23","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797780","article-title":"dNTP metabolism links mechanical cues and YAP\/TAZ to cell growth and oncogene-induced senescence","volume":"37","author":"Santinon","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.omton.2025.201032_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13578-021-00586-5","article-title":"RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS\/STING signaling pathway in lung adenocarcinoma","volume":"11","author":"Jiang","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.omton.2025.201032_bib25","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201181R","article-title":"VASN promotes colorectal cancer progression by activating the YAP\/TAZ and AKT signaling pathways via YAP","volume":"37","author":"Liang","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.omton.2025.201032_bib26","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1038\/s41467-021-22544-y","article-title":"Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP\/TAZ","volume":"12","author":"Della Chiara","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201032_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/15384101.2024.2309017","article-title":"YAP1 expression in colorectal cancer confers the aggressive phenotypes via its target genes","volume":"23","author":"Chen","year":"2024","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omton.2025.201032_bib28","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/0008-5472.CAN-22-2586","article-title":"Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer","volume":"83","author":"Jagadeeshan","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201032_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis","volume":"13","author":"Gao","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omton.2025.201032_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2022.02.083","article-title":"Knockdown of YAP\/TAZ sensitizes tamoxifen-resistant MCF7 breast cancer cells","volume":"601","author":"Kim","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omton.2025.201032_bib31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/onc.2016.292","article-title":"Aurora A kinase activates YAP signaling in triple-negative breast cancer","volume":"36","author":"Chang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.201032_bib32","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/1878-0261.13602","article-title":"TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling","volume":"18","author":"Marug\u00e1n","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2025.201032_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8842554","article-title":"Evaluation of Hippo Pathway and CD133 in Radiation Resistance in Small-Cell Lung Cancer","volume":"2021","author":"Yang","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.omton.2025.201032_bib34","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ajpath.2019.05.014","article-title":"The Expression of Yes-Associated Protein (YAP) Maintains Putative Cancer Stemness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma","volume":"189","author":"Sugiura","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omton.2025.201032_bib35","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1002\/jcp.30899","article-title":"CD133-Src-TAZ signaling stimulates ductal fibrosis following DDC diet-induced liver injury","volume":"237","author":"Oh","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.omton.2025.201032_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41419-022-04663-6","article-title":"MESH1 knockdown triggers proliferation arrest through TAZ repression","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2025.201032_bib37","doi-asserted-by":"crossref","first-page":"17726","DOI":"10.18632\/oncotarget.7394","article-title":"14-3-3\u03c3 regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2025.201032_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202100881","article-title":"RRM2 Regulates Sensitivity to Sunitinib and PD-1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway","volume":"8","author":"Xiong","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omton.2025.201032_bib39","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.3390\/cancers14122938","article-title":"Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer","volume":"14","author":"Zhou","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2025.201032_bib40","first-page":"2159","article-title":"Silencing RRM2 inhibits multiple myeloma by targeting the Wnt\/\u03b2-catenin signaling pathway","volume":"20","author":"Liu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omton.2025.201032_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2024.09.564","article-title":"03I.14 Osalmid Inhibits the Progression of Lung Adenocarcinoma and Sensitizes It to EGFR-TKIs: A Preclinical and Translational Study","volume":"19","author":"Wu","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.omton.2025.201032_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112347","article-title":"Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer","volume":"144","author":"Solanes-Casado","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omton.2025.201032_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.omton.2025.201032_bib44","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.omton.2025.201032_bib45","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.201032_bib46","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2025.201032_bib47","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"A Software Environment for Integrated Models of Biomolecular Interaction Networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.omton.2025.201032_bib48","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1093\/bioinformatics\/bti551","article-title":"BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks","volume":"21","author":"Maere","year":"2005","journal-title":"Bioinformatics"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:41:58Z","timestamp":1772923318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925001018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2950329925001018"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201032","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aurora kinase A drives non-canonical YAP1\/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201032"}}